Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2009-03, Vol.23 (3), p.617-619
Hauptverfasser:	Struski, S, Gervais, C, Helias, C, Herbrecht, R, Audhuy, B, Mauvieux, L
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities B-Lymphocytes - pathology Biological and medical sciences Cancer Research Cell Division - drug effects Cells, Cultured - drug effects Cells, Cultured - ultrastructure Chromosome Aberrations Chromosome Banding - methods Chronic lymphocytic leukemia Cohort Studies Critical Care Medicine Female Genetic aspects Hematologic and hematopoietic diseases Hematology Humans In Situ Hybridization, Fluorescence Intensive Interleukin 2 Interleukin-2 - pharmacology Internal Medicine Karyotyping - methods letter-to-the-editor Leukemia, Lymphocytic, Chronic, B-Cell - genetics Leukemia, Lymphocytic, Chronic, B-Cell - pathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphocyte Activation - drug effects Lymphocytes B Lymphoma, B-Cell - genetics Lymphoma, B-Cell - pathology Lymphoproliferative Disorders - genetics Lymphoproliferative Disorders - pathology Male Medical sciences Medicine Medicine & Public Health Metaphase Mitogens - pharmacology Oligonucleotides Oligonucleotides - pharmacology Oncology Physiological aspects Risk factors Tetradecanoylphorbol Acetate - pharmacology Translocation (Genetics)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!